Frank de Wolf

2.7k total citations · 1 hit paper
41 papers, 1.6k citations indexed

About

Frank de Wolf is a scholar working on Physiology, Infectious Diseases and Psychiatry and Mental health. According to data from OpenAlex, Frank de Wolf has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Infectious Diseases and 9 papers in Psychiatry and Mental health. Recurrent topics in Frank de Wolf's work include Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and HIV Research and Treatment (7 papers). Frank de Wolf is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (9 papers) and HIV Research and Treatment (7 papers). Frank de Wolf collaborates with scholars based in Netherlands, United Kingdom and United States. Frank de Wolf's co-authors include Roy M. Anderson, Christoforos Hadjichrysanthou, Albert Hofman, M. Arfan Ikram, Jaap Goudsmit, Ivo Brosens, W.B. Robertson, Jaap Goudsmit, Brian Sheppard and Kevin McRae‐McKee and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

Frank de Wolf

40 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

2020 215 citations Frank de Wolf, Mohsen Ghanbari et al. profile →

Peers

Countries citing papers authored by Frank de Wolf

Since Specialization

Citations

This map shows the geographic impact of Frank de Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank de Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank de Wolf more than expected).

Fields of papers citing papers by Frank de Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank de Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank de Wolf. The network helps show where Frank de Wolf may publish in the future.

Co-authorship network of co-authors of Frank de Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Frank de Wolf. A scholar is included among the top collaborators of Frank de Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank de Wolf. Frank de Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preventing SARS-CoV-2 superspreading events with antiviral intranasal sprays 2025 ·Journal of Theoretical Biology ·George H. Booth, Christoforos Hadjichrysanthou, (unknown), Jacopo Frallicciardi, Zoltán Magyarics, Frank de Wolf, Jaap Goudsmit, Anna L. Beukenhorst, Roy M. Anderson	0
2	SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies 2023 ·European Journal of Epidemiology ·Anna L. Beukenhorst, Clarissa M. Koch, Christoforos Hadjichrysanthou, Galit Alter, Frank de Wolf, Roy M. Anderson, Jaap Goudsmit	12
3	Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community 2022 ·Infectious Diseases and Therapy ·Christoforos Hadjichrysanthou, Anna L. Beukenhorst, Clarissa M. Koch, Galit Alter, Jaap Goudsmit, Roy M. Anderson, Frank de Wolf	6
4	The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease 2020 ·Alzheimer s Research & Therapy ·Christoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj, (unknown), Kevin McRae‐McKee, Frank de Wolf, Roy M. Anderson, (unknown)	64
5	Combining hippocampal volume metrics to better understand Alzheimer’s disease progression in at-risk individuals 2019 ·Scientific Reports ·Kevin McRae‐McKee, Stephanie Evans, Christoforos Hadjichrysanthou, Mei Mei Wong, Frank de Wolf, Roy M. Anderson	17
6	Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach 2019 ·European Journal of Epidemiology ·Reem Waziry, Luuk Gras, Sanaz Sedaghat, Henning Tiemeier, Gerrit Jan Weverling, Mohsen Ghanbari, J. Klap, Frank de Wolf, Albert Hofman, M. Arfan Ikram, Jaap Goudsmit	36
7	Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies 2018 ·Journal of Alzheimer s Disease ·Christoforos Hadjichrysanthou, (unknown), Kevin McRae‐McKee, Stephanie Evans, Frank de Wolf, Roy M. Anderson	7
8	The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments 2018 ·PLoS ONE ·Christoforos Hadjichrysanthou, Alison Ower, Frank de Wolf, Roy M. Anderson, (unknown)	27
9	The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment? 2018 ·European Journal of Epidemiology ·Stephanie Evans, Kevin McRae‐McKee, Mei Mei Wong, Christoforos Hadjichrysanthou, Frank de Wolf, Roy M. Anderson	20
10	A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers 2017 ·Journal of Alzheimer s Disease ·Emma Lawrence, Carolin Vegvari, Alison Ower, Christoforos Hadjichrysanthou, Frank de Wolf, Roy M. Anderson	60
11	Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease 2017 ·European Journal of Epidemiology ·(unknown), Alison Ower, Christoforos Hadjichrysanthou, Luuk Gras, Jaap Goudsmit, Roy M. Anderson, Frank de Wolf	22
12	Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections 2016 ·PLoS ONE ·Carolin Vegvari, (unknown), Christoforos Hadjichrysanthou, Emma Lawrence, (unknown), Frank de Wolf, Roy M. Anderson	5
13	Non-invasive, quantitative monitoring of hyperthermia-induced EGFR activation in xenograft tumours 2011 ·International Journal of Hyperthermia ·Frank de Wolf, Wenrong Li, Fang Li, Chuan‐Yuan Li	5
14	Novel Luciferase-Based Reporter System to Monitor Activation of ErbB2/Her2/neu Pathway Noninvasively During Radiotherapy 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Frank de Wolf, Wenrong Li, Fang Li, Chuan‐Yuan Li	14
15	Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts 2010 ·Cell stem cell ·Li Fang, Zhimin He, Jingping Shen, Qian Huang, Wenrong Li, Xinjian Liu, Yujun He, Frank de Wolf, Chuan‐Yuan Li	98
16	Mortality in Patients With Successful Initial Response to Highly Active Antiretroviral Therapy Is Still Higher Than in Non-HIV-Infected Individuals 2005 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Ard van Sighem, Sven A. Danner, Azra C. Ghani, Luuk Gras, Roy M. Anderson, Frank de Wolf	54
17	Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy 1999 ·AIDS ·Jan M. Prins, Suzanne Jurriaans, Rieneke M. E. van Praag, Hetty Blaak, Ronald P. van Rij, Peter Th.A. Schellekens, Ineke J. M. ten Berge, Si‐La Yong, Cecil H. Fox, Marijke Roos, Frank de Wolf, Jaap Goudsmit, Hanneke Schuitemaker, Joep M. A. Lange	193
18	Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals. 1990 ·PubMed ·Peter Reiss, Joep M. A. Lange, Anthony de Ronde, Frank de Wolf, John T. Dekker, Sven A. Danner, Christine Debouck, Jaap Goudsmit	20
19	Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression 1989 ·AIDS ·Charles A. Boucher, Frank de Wolf, (unknown), Margreet Bakker, John T. Dekker, Marijke Th. L. Roos, Roel A. Coutinho, J. van der Noordaa, Jaap Goudsmit	19
20	Low AIDS Attack Rate Among Dutch Haemophiliacs Compared to Homosexual Men: A Correlate of HIV Antigenaemia Frequencies 1989 ·Vox Sanguinis ·Tom F.W. Wolfs, Frank de Wolf, C. Breederveld, (unknown), Marijke Roos, Margreet Bakker, Jaap Goudsmit	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact